Impact of clinicopathological features on the efficacy of immune checkpoint inhibitors plus conventional treatment in patients with advanced lung cancer

BACKGROUND: To investigate the impact of different immune checkpoint inhibitors (ICI), programmed-death ligand 1 (PD-L1) expression and clinical characteristics on clinical outcome of ICI plus conventional treatment in advanced lung cancer patients. METHODS: Randomized clinical trials that compared...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Thorac Dis
Auteurs principaux: Gao, Guanghui, Qiao, Meng, Liu, Hongcheng, Jiang, Tao, Zhou, Fei, Li, Xuefei, Zhao, Chao, Chen, Xiaoxia, Su, Chunxia, Ren, Shengxiang, Zhou, Caicun
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2019
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790436/
https://ncbi.nlm.nih.gov/pubmed/31656652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.09.19
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires